Thursday, May 6, 2021

Advertising

Home Business News CM Life Sciences III Inc., Sponsored by Affiliates of Casdin Capital and...

CM Life Sciences III Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announce…


NEW YORK–()–CM Life Sciences III Inc. (the “Company”) announced today that it closed its initial public offering of 55,200,000 units at $10.00 per unit, including 7,200,000 units issued pursuant to the exercise in full by the underwriters of its over-allotment option. The units are listed on The Nasdaq Capital Market (“Nasdaq”) and began trading under the ticker symbol “CMLTU” on April 7, 2021. Each unit consists of one share of Class A common stock and one-fifth of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock…



Click here to view the original article.

- Advertisment -
- Advertisment -

Recently Viewed

You might also like ...

Article feature image
Results tally up billions in profit from Texas freeze for gas and power sellers
Article feature image
ACCC may stop Qantas’ Japan flights bid